Home › Funds › Concentric Capital Strategies, LP › JNJ

Concentric Capital Strategies, LP position in JNJ

JOHNSON & JOHNSON · Health Care

Concentric Capital Strategies, LP reported holding 42,565 shares of JNJ (JOHNSON & JOHNSON) in its Q2 2026 13F filing — a position valued at US$10.8M, representing 0.61% of its reported portfolio and ranking #15 among its reported holdings. Concentric Capital Strategies, LP has disclosed JNJ holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)42.56K sh
Reported value held$10.81M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Concentric Capital Strategies, LP's JNJ position evolved

Concentric Capital Strategies, LP first disclosed a stake in JNJ in Q3 2023 at 3,268 shares (US$509K). The position peaked in Q2 2026 at 42,565 shares, worth US$10.8M. Across 9 filings, Concentric Capital Strategies, LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 42,565 shares valued at US$10.8M — an increase of 34,377 shares quarter over quarter.. Notable position changes include a 73% trim in Q4 2024 (shares rose 12% over the following quarter), a 851% increase in Q4 2025 (shares rose 18% over the following quarter), a 420% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.27K $508.99K New
Q2 2024 6.04K $883.10K New
Q3 2024 10.06K $1.63M Add
Q4 2024 2.72K $393.37K Reduce
Q2 2025 2.85K $436.10K New
Q3 2025 2.97K $550.33K Add
Q4 2025 28.23K $5.84M Add
Q1 2026 8.19K $2.00M Reduce
Q2 2026 42.56K $10.81M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Concentric Capital Strategies, LP held JNJ?

Concentric Capital Strategies, LP has disclosed JNJ holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

What is Concentric Capital Strategies, LP's current position in JNJ?

As of Q2 2026, Concentric Capital Strategies, LP holds 42.56K shares of JNJ (JOHNSON & JOHNSON), valued at $10.81M, representing 0.61% of its reported portfolio and ranking #15.

Has Concentric Capital Strategies, LP been buying or selling JNJ?

In the latest 13F filing (Q2 2026), Concentric Capital Strategies, LP increased its position in JNJ. The position peaked in Q2 2026 at 42.56K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.